Phase I/II trial of vandetanib in children and adolescents with hereditary medullary thyroid carcinoma

被引：0
|
作者：
Fox, E.
Widemann, B. C.
Whitcomb, P. O.
Aikin, A.
Dombi, E.
Lodish, M.
Stratakis, C. A.
Steinberg, S.
Wells, S. A., Jr.
Balis, F. M.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] NICHD, Bethesda, MD USA
[3] Washington Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10014
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib
    Kraft, Ira L.
    Akshintala, Srivandana
    Zhu, Yuelin
    Lei, Haiyan
    Derse-Anthony, Claudia
    Dombi, Eva
    Steinberg, Seth M.
    Lodish, Maya
    Waguespack, Steven G.
    Kapustina, Oxana
    Fox, Elizabeth
    Balis, Frank M.
    Merino, Maria J.
    Meltzer, Paul S.
    Glod, John W.
    Shern, Jack F.
    Widemann, Brigitte C.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (04) : 753 - 765
  • [2] A PHASE II STUDY OF VANDETANIB IN METASTATIC HEREDITARY MEDULLARY THYROID CANCER
    Paz-Ares, L.
    Haddad, R.
    Krebs, A. D.
    Vasselli, J.
    Robinson, B.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 247 - 247
  • [3] UPDATED OUTCOMES OF CHILDREN WITH HEREDITARY MEDULLARY THYROID CARCINOMA (MTC) TREATED WITH VANDETANIB
    Lodish, Maya B.
    Kraft, Ira
    Srivandana, Akshintala
    Derse-Anthony, Claudia
    Steinberg, Seth
    Venzon, David
    Dombi, Eva
    Waguespack, Steven G.
    Kapustina, Oxana
    Fox, Elizabeth
    Balis, Frank M.
    Shern, John F.
    Glod, John W.
    Widemann, Brigitte C.
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 387 - 387
  • [4] Outcomes of children with hereditary medullary thyroid carcinoma (MTC) treated with vandetanib.
    Kraft, Ira Lignugaris
    Akshintala, Srivandana
    Derse-Anthony, Claudia
    Steinberg, Seth M.
    Venzon, David J.
    Dombi, Eva
    Waguespack, Steven G.
    Kapustina, Oxana Borisovna
    Fox, Elizabeth
    Balis, Frank M.
    Shern, John Frederick
    Glod, John
    Widemann, Brigitte C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer
    Del Rivero, Jaydira
    Edgerly, Maureen
    Ward, Jean
    Madan, Ravi A.
    Balasubramaniam, Sanjeeve
    Fojo, Tito
    Gramza, Ann W.
    [J]. ONCOLOGIST, 2019, 24 (01): : 16 - +
  • [6] Phase I/II trial of vandetanib and bortezomib in adults with locally advanced or metastatic medullary thyroid cancer: Phase I results.
    Gramza, A. W.
    Wells, S. A.
    Balasubramaniam, S.
    Fojo, A. T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Vandetanib in metastatic hereditary medullary thyroid cancer: Follow-up results of an open-label phase II trial
    Wells, S. A., Jr.
    Gosnell, J. E.
    Gagel, R. F.
    Moley, J. F.
    Pfister, D. G.
    Sosa, J. A.
    Skinner, M.
    Krebs, A.
    Hou, J.
    Schlumberger, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Vandetanib for the Treatment of Medullary Thyroid Carcinoma
    Cooper, Maryann R.
    Yi, Soo Yun
    Alghamdi, Wael
    Shaheen, Daniel J.
    Steinberg, Michael
    [J]. ANNALS OF PHARMACOTHERAPY, 2014, 48 (03) : 387 - 394
  • [9] Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents
    Eckelt, Felix
    Pfaeffle, Roland
    Kiess, Wieland
    Kratzsch, Juergen
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2021, 34 (12): : 1491 - 1504
  • [10] Phase II trial of sorafenib for advanced or metastatic medullary thyroid carcinoma and anaplastic thyroid carcinoma
    Ito, Ken-ichi
    [J]. ANNALS OF ONCOLOGY, 2016, 27
12345